Working with Community Advisory Boards: Guidance and tools for patient communities and pharmaceutical companies

Working with Community Advisory Boards: Guidance and Tools for Patient Communities and Pharmaceutical Companies Working with Community Advisory Boards: Guidance and Tools for Patient Communities and Pharmaceutical Companies | IHI (formerly IMI) PARADIGM A toolkit encompassing guidance and resources related to community and patient advocacy in the healthcare industry. View Read more…

Guidance for Patient Involvement in Regulatory Processes

Guidance for Patient Involvement in Regulatory Processes Guidance for Patient Involvement in Regulatory Processes | EUPATI “This guidance for PAGs covers patient involvement in the regulatory field and draws on the mature “Framework for interaction between the European Medicines Agency and patients and consumers and their organisations” “”Guidance for patient Read more…

How-to Guide on Patient Engagement in Clinical Trial Protocol Design

How-to Guide on Patient Engagement in Clinical Trial Protocol Design How-to Guide on Patient Engagement in Clinical Trial Protocol Design | PFMD “PFMD: The guide will give more clarity, instructions and the key terminology to Patients, Carers, Patient Organizations, Industry (Pharma, Biotech, Devices), Academia, Researchers, Contract Research Organisations (CROs) on Read more…

Patient Engagement in Medicines Development: Recommendations on how to find the right match for the right patient engagement activity

Patient Engagement in Medicines Development: Recommendations on How to Find the Right Match for the Right Patient Engagement Activity Patient Engagement in Medicines Development: Recommendations on how to find the right match for the right patient engagement activity | IHI (formerly IMI) PARADIGM PARADIGM: Guidance for Industry and PAGs providing Read more…